Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin

Headache

Volumn 47, Issue 2, 2007, Pages 225-235

  Gupta, Saurabh ^a   Villalón, Carlos M ^b   Mehrotra, Suneet ^a   De Vries, René ^a   Garrelds, Ingrid M ^a   Saxena, Pramod R ^a   MaassenVanDenBrink, Antoinette ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

17 estradiol; Calcitonin gene related peptide; Capsaicin; Intravital microscopy; Migraine; Progesterone

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; ESTRADIOL; PLACEBO; PROGESTERONE; SEX HORMONE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DURA MATER; ELECTROSTIMULATION; FEMALE; HORMONAL REGULATION; MENINGEAL ARTERY; MICROSCOPY; MIGRAINE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DURA MATER; ELECTRIC STIMULATION; ESTRADIOL; FEMALE; MENINGEAL ARTERIES; MIGRAINE DISORDERS; OVARIECTOMY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

EID: 33847008079     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00526.x     Document Type: Article

References (60)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American migraine study II. Headache. 2001;41:646-657.
2. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. J Am Med Assoc. 1992;267:64-69.
3. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;134:1111-1120.
4. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353.
5. Silberstein SD. Headaches in pregnancy. Neurol Clin. 2004;22:727-756.
6. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache. 2003;43:470-478.
7. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
8. Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology. 1975;25:245-250.
9. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000;60:1259-1287.
10. 1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Philadelphia: Lippincott Williams & Wilkins; 2005:469-503.
11. Durham P, Russo A. New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol Ther. 2002;94:77-92.
12. Doods H, Hallermayer G, Wu D, et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol. 2000;129:420-423.
13. Edvinsson L, Alm R, Shaw D, et al. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SKN-MC cells. Eur J Pharmacol. 2002;434:49-53.
14. Kapoor K, Arulmani U, Heiligers JP, et al. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur J Pharmacol. 2003;475:69-77.
15. Kapoor K, Arulmani U, Heiligers JP, et al. Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol. 2003;140:329-338.
16. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-1110.
17. Gangula PR, Zhao H, Wimalawansa SJ, Supowit SC, DiPette DJ, Yallampalli C. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod. 2001;64:1776-1783.
18. Dong YL, Fang L, Kondapaka S, Gangula PR, Wimalawansa SJ, Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest. 1999;104:559-565.
19. Ma QL, Zhou HY, Sun M. [Relationship between sex hormone levels and blood calcitonin gene-related peptide/endothelin-1 in postmenopausal women with coronary heart disease]. Hunan Yi Ke Da Xue Xue Bao. 2001;26:146-148.
20. Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G, Sances G. Hormone supplementation differently affects migraine in postmenopausal women. Headache. 2002;42:924-929.
21. Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas. 2001;38:157-163.
22. Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech. 2001;53:167-178.
23. Escott KJ, Beattie DT, Connor HE, Brain SD. Trigeminal ganglion stimulation increases facial skin blood flow in the rat: A major role for calcitonin generelated peptide. Brain Res. 1995;669:93-99.
24. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat - intravital microscope studies. Cephalalgia. 1997;17:525-531.
25. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia. 1997;17:518-524.
26. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels. Eur J Pharmacol. 2002;452:223-228.
27. Akerman S, Kaube H, Goadsby PJ. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther. 2004;309:56-63.
28. Petersen KA, Birk S, Doods H, Edvinsson L, Olesen J. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol. 2004;143:697-704.
29. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002;346:257-270.
30. Arulmani U, Gupta S, MaassenVanDenBrink A, Centurión D, Villalón CM, Saxena PR. Experimental migraine models and their relevance in migraine therapy. In: Cephalalgia, 2006, pp. http://www. blackwellsynergy.com/doi/abs/10.1111/j.1468-2982.2005.01082.x.
31. 1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol. 2003;140:718-724.
32. 1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology. 1997;36:525-533.
33. Messlinger K, Hanesch U, Kurosawa M, Pawlak M, Schmidt RF. Calcitonin gene related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol. 1995;73:1020-1024.
34. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005;315:1380-1385.
35. Just S, Arndt K, Doods H. The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes. Neurosci Lett. 2005;381:120-124.
36. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: Some helpful considerations. Braz J Biol. 2002;62:609-614.
37. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5:197-216.
38. Pedersen SB, Borglum JD, Moller-Pedersen T, Richelsen B. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol. 1992;85:13-19.
39. Hamosh M, Hamosh P. The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. J Clin Invest. 1975;55:1132-1135.
40. Kim HJ, Kalkhoff RK. Sex steroid influence on triglyceride metabolism. J Clin Invest. 1975;56:888-896.
41. Steingrimsdottir L, Brasel J, Greenwood MR. Hormonal modulation of adipose tissue lipoprotein lipase may alter food intake in rats. Am J Physiol. 1980;239:E162-E167.
42. Grewal M, Cuevas J, Chaudhuri G, Nathan L. Effects of calcitonin gene-related peptide on vascular resistance in rats: Role of sex steroids. Am J Physiol. 1999;276: H2063-H2068.
43. O'Connor TP, Van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 1988;8:2468-2476.
44. Lee Y, Kawai Y, Shiosaka S, et al. Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: Immunohistochemical analysis. Brain Res. 1985;330:194-196.
45. Strassman AM, Weissner W, Williams M, Ali S, Levy D. Axon diameters and intradural trajectories of the dural innervation in the rat. J Comp Neurol. 2004;473:364-376.
46. Blacklock AD, Cauveren JA, Smith PG. Estrogen selectively increases sensory nociceptor innervation of arterioles in the female rat. Brain Res. 2004;1018:55-65.
47. Blacklock AD, Smith PG. Estrogen increases calcitonin gene-related peptide-immunoreactive sensory innervation of rat mammary gland. J Neurobiol. 2004;59:192-204.
48. Gangula PR, Lanlua P, Wimalawansa S, Supowit S, DiPette D, Yallampalli C. Regulation of calcitonin gene-related peptide expression in dorsal root ganglia of rats by female sex steroid hormones. Biol Reprod. 2000;62:1033-1039.
49. Lanlua P, Gangula PR, Taglialatela G, Yallampalli C. Gestational changes in calcitonin gene-related peptide, nerve growth factor, and its receptors in rat dorsal root ganglia. Biol Reprod. 2001;65:1601-1605.
50. Moura MJ, Marcondes FK. Influence of estradiol and progesterone on the sensitivity of rat thoracic aorta to noradrenaline. Life Sci. 2001;68:881-888.
51. Cox MW, Fu W, Chai H, et al. Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res. 2005;124:104-111.
52. Dong YL, Vegiraju S, Gangula PR, Kondapaka SB, Wimalawansa SJ, Yallampalli C. Expression and regulation of calcitonin gene-related Peptide receptor in rat placentas. Biol Reprod. 2002;67:1321-1326.
53. A-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol. 1996;117:99-104.
54. Cutrer FM, Moskowitz MA. The actions of valproate and neurosteroids in a model of trigeminal pain. Headache. 1996;36:579-585.
55. Akerman S, Williamson DJ, Goadsby PJ. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br JPharmacol. 2003;140:558-566.
56. Mitchell RW, Ndukwu IM, Herrnreiter A, et al. Differential tachykinin receptor subtype activation in capsaicin and KCl contractions of guinea pig trachealis. Am J Physiol. 1995;269:L837-L842.
57. Donnerer J, Lembeck F. Analysis of the effects of intravenously injected capsaicin in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1982;320:54-57.
58. Bennett AD, Chastain KM, Hulsebosch CE. Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain. 2000;86:163-175.
59. Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol. 2000;131:875-884.
60. 1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol. 2001;133:1029-1034.